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( )1.经厦门大学保密委员会审查核定的保密学位论文，于  






































内皮生长因子(vascular endothelial growth factor, VEGF)、含激酶插入区受体






病理切片；并运用酶联免疫吸附测定(enzyme linked immunosorbent assay, 
ELISA)肝组织 VEGF 蛋白含量；蛋白印迹法(Western blotting)测定小鼠肝脏
AKT、pAKT、KDR 和 Flt-1 蛋白的表达；逆转录 PCR(reverse transcription po-
























2. 经 THSWD 治疗后，中药复方高、中剂量组肝组织 VEGF 蛋白表达量较
模型组降低(P<0.05 或 P<0.01)，复方高、中剂量组及西药秋水仙碱组 AKT 蛋
白表达量明显低于模型组(P<0.01)。西药秋水仙碱组及 THSWD 高剂量组
pAKT 蛋白表达量明显低于模型组(P<0.01 或 P<0.05)。中药高剂量组肝组织
KDR 与 Flt-1 蛋白表达较模型组降低(P<0.05)，低剂量组较之无差异；而
THSWD 高中剂量组肝组织 VEGF、KDR 及 Flt-1 mRNA 表达较模型组、秋水仙
碱组明显减少(P<0.01)，并且呈现一定的量效正相关性。THSWD 高剂量组与






















Background: Tao-Hong-Si-Wu decoction (THSWD) is a traditional Chinese 
herbal medicine that has been used for centuries in the treatment of Chinese patients 
with chronic liver disease. Recently, THSWD has been reported to alter vascular 
endothelial growth factor (VEGF) induced angiogenesis, raising the possibility that in 
addition to its anti-inflammatory properties; THSWD might also inhibit hepatic blood 
flow associated fibrosis. 
Objective: To document the effects of THSWD on hepatic necroinflammatory 
disease activity, fibrosis and VEGF signaling in a murine model of chronic liver 
disease. 
Methods: Sixty adult mice were equally divided into six study groups. Five 
groups were exposed to subcutaneous carbon tetrachloride (0.1 mL/10g BW) for six 
weeks. Three of the five groups were treated with different concentrations of THSWD 
(4.25, 8.50, 17.00 g/kg), one with 0.1 mg/kg of Colchicine (positive control), and one 
with physiologic saline (negative control). Mice in the sixth group were not exposed 
to CCl4 and remained untreated (healthy controls). Liver enzymes/function tests, 
hyaluronic acid and laminin levels were measured in serum, and hepatic histology, 
VEGF, Flt-1 and kinase insert domaincontaining receptor (KDR), Akt and 
phosphorylated Akt (pAkt) expression were documented in liver tissue at the end of 
treatment. 
Results: Hepatic necroinflammatory disease activity and fibrosis were 
significantly attenuated in THSWD treated mice in a dose dependent manner.These 
benefical results were similar and often exceeded those achieved with colchicine.In 
addition, VEGF, Flt-1, KDR, Akt and pAkt mRNA and protein expression were 
reduced in TSHWD treated mice.VEGF protein content in THSWD (17.00g/kg and 
8.50g/kg) groups was lower than that in model group (P<0.05 or P<0.01); protein 
expression of liver tissue KDR and Flt-1 in THSWD (17.00g/kg) group was less than 
that in model group (P<0.05); mRNA expression of liver tissue VEGF, KDR and Flt-
1 was significantly lower than that in both model and colchicine groups (P<0.01), 
which showed a certain positive correlation between dose and effect.  
Conclusion: In this animal model of chronic liver disease, THSWD decreased 
















downstream signaling were associated with these findings. Further studies with this 
and other TCMs as treatment for chronic liver disease are warranted. 
Keywords: Tao-Hong-Si-Wu Decoction (THSWD); pathological angiogenesis; 

















英文缩写 英文全称 中文全称 
THSWD Tao-Hong-Si-Wu Decoction 桃红四物汤 
HF Hepatic fibrosis 肝纤维化 
ECM Extracellular matrix 细胞外基质 
MFB Myofibroblast, 肌成纤维细胞 
KM Kunming 昆明种小鼠 
CCL4 Carbon tetrachloride 四氯化碳 
Colc Colchicine Tablets 秋水仙碱片 
ALT Albumin 白蛋白 
TBIL Total bilirubin 血清总胆红素 
ALT Alanine aminotransferase 谷氨酸氨基转移酶 
AST Aspartate transaminase 天冬氨酸氨基转移酶 
HA Hyaluronan 透明质酸 
LN Laminin 层粘连蛋白 
VEGF Vascular endothelial growth factor 血管内皮生长因子 
KDR Kinase insert domain containing re-ceptor 含激酶插入区受体 
PBS Phosphate buffered saline 磷酸盐缓冲液 
HE Hematoxylin-eosin staining 苏木精-伊红染色法 
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